Weight Loss News and Research

Latest Weight Loss News and Research

FREEDRUGCARD.US launches new Rx savings program to reduce prescription drug prices

If you are looking for the best way to save money on your prescription drugs then FREEDRUGCARD.US is your best option. The free prescription assistance drug card program is sponsored by a non-profit organization and was launched to help all Americans lower the cost of prescription drugs.

31 Dec 2009

Food addiction remains largely ignored but can be easily overcome, says psychologist

As holiday parties give way to New Year's resolutions, rehabs across the country become inundated, making early January one of the industry's busiest times of the year.

31 Dec 2009

Dr. Ken Hopper of LifeSynch offers simple tips toward achieving New Year's weight loss resolution

It's that time of year. Gyms will be flooded with people ready to step on a treadmill. Grocery carts will be filled with fruits and vegetables instead of frozen pizza and chips. People will enter the New Year resolved to lose weight. But surveys show that most people don't keep this resolution.

31 Dec 2009

Website explores pros and cons of obesity

ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://www.obesity.procon.org to explore the core question "Is obesity a disease?"

30 Dec 2009

Nutrisystem to take non cash charge of $5 million as impairment charge

Nutrisystem, Inc., a leading provider of weight management products and services, today announced that it expects to take a non cash charge of up to $5 million before taxes to reflect an impairment charge on the value of the goodwill and identifiable intangibles related to its Nu-Kitchen fresh food delivery business that currently services the New York City area, which the company acquired in July 2008.

30 Dec 2009

Majority of Americans fail at keeping their New Years resolutions to lose weight and get in shape

Nutritionist Judy Pentra, of Patients Medical, a multi-specialty wellness center in New York, warns that the New Year can be a vulnerable time for people trying to lose weight and get in shape. The average person can gain 2-5 pounds during the holidays and many resolve to lose the weight in January, however, 70 percent of Americans fail at keeping their New Years resolutions.

30 Dec 2009

CORE, a biopsychosocial treatment center for weight loss

Earlier this month, leaders in the treatment of weight related disorders and psychiatry joined forces under the Comprehensive Obesity Recovery Effort (CORE, LLC).

30 Dec 2009

VIVUS submits a NDA to the FDA for obesity drug Qnexa

VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.

30 Dec 2009

Smart for Life introduces new THIN ADVENTURE Children's Weight Loss Program

With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.

29 Dec 2009

Nutrient-rich foods for weight loss

For the majority of Americans who are unhappy with their weight at any given moment, the New Year brings mixed emotions: the renewed resolution to shed pounds and the challenge of learning how to eat right to reach those goals.

29 Dec 2009

Perspective of the future influences health decisions

When New Year's Eve rolls around and you're deciding whether to have another glass of champagne, your decision may be predicted by your perspective of the future.

24 Dec 2009

Orexigen Therapeutics' Compensation Committee approves inducement grants

Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.

24 Dec 2009

Intervention strategy brings positive changes in type 2 diabetic patients

South Dakota State University research showed an intervention strategy based on the Native American spiritual concept of the Medicine Wheel brought positive changes for diabetics.

24 Dec 2009

ABBM grants certification for medical community who treats obesity and related conditions

The American Board of Bariatric Medicine (ABBM) recently administered its certification exam designed to recognize doctors, nurse practitioners and physicians assistants who practice bariatric medicine and the non-surgical medical management of overweight and obese patients.

23 Dec 2009

Tips to achieve fitness and weight loss goals

More than 100 million Americans made New Year resolutions for 2009, and four out of five were not able to stick with them, according to the third annual Franklin Covey New Year’s Resolution survey released in January 2009.

23 Dec 2009

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.

22 Dec 2009

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss. The submission is based on an extensive data package from lorcaserin's clinical development program that includes 18 clinical trials totaling 8,576 patients.

22 Dec 2009

Weight Loss News and Research

Latest Weight Loss News and Research

FREEDRUGCARD.US launches new Rx savings program to reduce prescription drug prices

Food addiction remains largely ignored but can be easily overcome, says psychologist

Dr. Ken Hopper of LifeSynch offers simple tips toward achieving New Year's weight loss resolution

Website explores pros and cons of obesity

Nutrisystem to take non cash charge of $5 million as impairment charge

Majority of Americans fail at keeping their New Years resolutions to lose weight and get in shape

CORE, a biopsychosocial treatment center for weight loss

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smart for Life introduces new THIN ADVENTURE Children's Weight Loss Program

Nutrient-rich foods for weight loss

Perspective of the future influences health decisions

Orexigen Therapeutics' Compensation Committee approves inducement grants

Intervention strategy brings positive changes in type 2 diabetic patients

ABBM grants certification for medical community who treats obesity and related conditions

Tips to achieve fitness and weight loss goals

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

DMC launches Dental Optimizer, a free online application connected to Microsoft HealthVault

SLIMR gastric band makes its debut in the US at Tooley Weight Wellness Clinic

Unigene Laboratories selects UGP281 lead peptide from obesity program for development

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Weight Loss News and Research

Latest Weight Loss News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in